撤回された事前の出版物.

Peter B Dean

Lancet (London, England)

|March 21, 2007

まとめ

No abstract available in PubMed .

関連する概念動画

こちらも読む

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え

Same author

Imaging biomarkers are key to recognizing fatal breast cancers arising in the major ducts.

European journal of radiology·2025

Same author

Metaplastic Breast Carcinoma and Mesenchymal Features of Other Breast Malignancies.

Academic radiology·2024

Same author

A plea for more careful scholarship in reviewing evidence: the case of mammographic screening.

BJR open·2023

Same author

The term "classic invasive lobular carcinoma" of the breast defines breast malignancies of vastly different nature.

European journal of radiology·2023

Same author

Imaging biomarkers are underutilised but highly predictive prognostic factors for the more fatal breast cancer subtypes.

European journal of radiology·2023

Same author

Does Diffusely Infiltrating Lobular Carcinoma of the Breast Arise from Epithelial-Mesenchymal Hybrid Cells?

International journal of molecular sciences·2023

Same journal

Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

Lancet (London, England)·2026

Same journal

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Lancet (London, England)·2026

Same journal

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

Lancet (London, England)·2026

Same journal

The US Ebola response and the future of global health leadership.

Lancet (London, England)·2026

Same journal

Daniel Mason: a tale of change.

Lancet (London, England)·2026

Same journal

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

Lancet (London, England)·2026

関連する実験動画

撤回された事前の出版物.

関連する概念動画

Imaging biomarkers are key to recognizing fatal breast cancers arising in the major ducts.

Metaplastic Breast Carcinoma and Mesenchymal Features of Other Breast Malignancies.

A plea for more careful scholarship in reviewing evidence: the case of mammographic screening.

The term "classic invasive lobular carcinoma" of the breast defines breast malignancies of vastly different nature.

Imaging biomarkers are underutilised but highly predictive prognostic factors for the more fatal breast cancer subtypes.

Does Diffusely Infiltrating Lobular Carcinoma of the Breast Arise from Epithelial-Mesenchymal Hybrid Cells?

Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

The US Ebola response and the future of global health leadership.

Daniel Mason: a tale of change.

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

関連する実験動画

撤回された事前の出版物.

関連する概念動画

Imaging biomarkers are key to recognizing fatal breast cancers arising in the major ducts.

Metaplastic Breast Carcinoma and Mesenchymal Features of Other Breast Malignancies.

A plea for more careful scholarship in reviewing evidence: the case of mammographic screening.

The term "classic invasive lobular carcinoma" of the breast defines breast malignancies of vastly different nature.

Imaging biomarkers are underutilised but highly predictive prognostic factors for the more fatal breast cancer subtypes.

Does Diffusely Infiltrating Lobular Carcinoma of the Breast Arise from Epithelial-Mesenchymal Hybrid Cells?

Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

The US Ebola response and the future of global health leadership.

Daniel Mason: a tale of change.

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

関連する実験動画

撤回された事前の出版物.

関連する概念動画

関連記事

Imaging biomarkers are key to recognizing fatal breast cancers arising in the major ducts.

Metaplastic Breast Carcinoma and Mesenchymal Features of Other Breast Malignancies.

A plea for more careful scholarship in reviewing evidence: the case of mammographic screening.

The term "classic invasive lobular carcinoma" of the breast defines breast malignancies of vastly different nature.

Imaging biomarkers are underutilised but highly predictive prognostic factors for the more fatal breast cancer subtypes.

Does Diffusely Infiltrating Lobular Carcinoma of the Breast Arise from Epithelial-Mesenchymal Hybrid Cells?

Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

The US Ebola response and the future of global health leadership.

Daniel Mason: a tale of change.

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?

関連する実験動画

撤回された事前の出版物.

関連する概念動画

関連記事

Imaging biomarkers are key to recognizing fatal breast cancers arising in the major ducts.

Metaplastic Breast Carcinoma and Mesenchymal Features of Other Breast Malignancies.

A plea for more careful scholarship in reviewing evidence: the case of mammographic screening.

The term "classic invasive lobular carcinoma" of the breast defines breast malignancies of vastly different nature.

Imaging biomarkers are underutilised but highly predictive prognostic factors for the more fatal breast cancer subtypes.

Does Diffusely Infiltrating Lobular Carcinoma of the Breast Arise from Epithelial-Mesenchymal Hybrid Cells?

Convergence of metabolic risk in obesity and normal BMI: does risk disappear?

Metabolic traits in obesity and normal BMI in industrialised countries: a multi-country analysis of national population-based studies.

Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective.

The US Ebola response and the future of global health leadership.

Daniel Mason: a tale of change.

The 2026 Wakley-Wu Lien Teh Prize Essay: why medicine, and why stay?